These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15742356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
    Piras F, Murtas D, Minerba L, Ugalde J, Floris C, Maxia C, Colombari R, Perra MT, Sirigu P.
    Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
    [Abstract] [Full Text] [Related]

  • 6. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
    Albert JM, Gonzalez A, Massion PP, Chen H, Olson SJ, Shyr Y, Diaz R, Lambright ES, Sandler A, Carbone DP, Putnam JB, Johnson DH, Lu B.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1845-51. PubMed ID: 17855704
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining.
    Skagias L, Politi E, Karameris A, Sambaziotis D, Archondakis A, Ntinis A, Moreas I, Vasou O, Koutselini H, Patsouris E.
    Anticancer Res; 2009 Oct; 29(10):4163-7. PubMed ID: 19846967
    [Abstract] [Full Text] [Related]

  • 9. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
    Fan J, Wang L, Jiang GN, He WX, Ding JA.
    Lung Cancer; 2008 Jul; 61(1):91-6. PubMed ID: 18192073
    [Abstract] [Full Text] [Related]

  • 10. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M, Kaibara N.
    Br J Cancer; 2002 Oct 07; 87(8):883-7. PubMed ID: 12373603
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH, Choi HY, Lee J, Son DS, Lee HS, Song IS, Lim YS, Hong YS, Kim J, Choi YS.
    J Surg Oncol; 2007 Mar 15; 95(4):337-46. PubMed ID: 17326127
    [Abstract] [Full Text] [Related]

  • 14. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 15; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 15. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 15; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 16. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H.
    Lung Cancer; 2009 Jul 15; 65(1):98-104. PubMed ID: 19081160
    [Abstract] [Full Text] [Related]

  • 17. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
    Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A.
    Oncol Rep; 2002 Jul 15; 9(4):835-8. PubMed ID: 12066218
    [Abstract] [Full Text] [Related]

  • 18. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 19. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 20. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
    Mohamed S, Yasufuku K, Nakajima T, Hiroshima K, Chiyo M, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Agamy G, El-Shahhat H, Fujisawa T, Yoshino I.
    Eur Respir J; 2009 Jan 01; 33(1):127-33. PubMed ID: 18715879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.